BioCentury
ARTICLE | Clinical News

AV4025: Phase Ib started

May 19, 2014 7:00 AM UTC

AllaChem began a double-blind, placebo-controlled, Russian Phase Ib trial to evaluate 20 or 40 mg oral AV4025 once daily for 3 days in about 20 treatment-naïve patients with HCV infection. ...